By Professor Andrew Lloyd

Conference Papers

TAUB DD; LLOYD AL; CONLON K; MURPHY W; LONGO DL; KELVIN DJ; OPPENHEIM JJ, 1993, 'PREFERENTIAL CHEMOTAXIS AND ADHESION OF T-CELL SUBSETS IN RESPONSE TO MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA (MIP-1-ALPHA), MIP-1-BETA, AND RANTES', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, pp. A46 - A46, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993KX95600257&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hickie IB; Hickie C; Bennett BH; Wakefield D; Silove DM; Mitchell PB; Lloyd AR, 1993, 'Biochemical correlates of in vivo cell-mediated immune dysfunction in patients with depression - a preliminary report', in International Journal of Immunopharmocology, Elsevier Science, UK, presented at Psychoimmune networks on Health and Disease, Sydney, 01 April 1993 - 03 April 1993

Wilson AR; Hickie IB; Lloyd AR; Hadzi-Pavlovic D; Wakefield D, 1993, 'Cell-mediated function and the outcome of chronic fatigue syndrome', in International Journal of Immunopharmocology, Elsevier Science, UK, presented at Psychoimmune networks on Health and Disease, Sydney, 01 April 1993 - 03 April 1993

Hickie C; Hickie IB; Silove DM; Wakefield D; Lloyd AR, 1993, 'Delayed-type hypersensitivity skin testing - normal values in the Australian population (17)', in International Journal of Immunopharmocology, Elsevier Science, UK, presented at Psychoimmune networks on Health and Disease, Sydney, 01 April 1993 - 03 April 1993

LLOYD A; TAUB D; CONLON K; MATSUSHIMA K; OPPENHEIM J; KELVIN D, 1993, 'REGULATION OF T-CELL SUBSET ADHESION BY CHEMOKINE FAMILY MEMBERS', in JOURNAL OF CELLULAR BIOCHEMISTRY, WILEY-LISS, pp. 92 - 92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993KN46500332&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

PALLADINETTI P; BROCKMAN A; HALES J; GANDEVIA S; WAKEFIELD D; LLOYD A, 1993, 'CYTOKINE PRODUCTION IN PATIENTS WITH CHRONIC FATIGUE SYNDROME', in JOURNAL OF LEUKOCYTE BIOLOGY, FEDERATION AMER SOC EXP BIOL, pp. 54 - 54, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993ME18500123&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lloyd AR; Johnston J, 1993, 'Cytokines and cytokine receptors in health and disease. A summary of the National Heart, Lung and Blood Institute Frontiers in Basic Sciences Symposium, December 2-3, 1992', in Cytokine, pp. 399 - 406, http://dx.doi.org/10.1016/1043-4666(93)90029-5

LLOYD A; TAUB D; WANG JM; JOHNSTON J; OPPENHEIM J; KELVIN D, 1993, 'FUNCTIONAL AND PROMISCUOUS CHEMOKINE RECEPTORS ENCODED BY HUMAN CYTOMEGALOVIRUS', in JOURNAL OF LEUKOCYTE BIOLOGY, FEDERATION AMER SOC EXP BIOL, pp. 131 - 131, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993ME18500586&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

LLOYD A; BIRAGYN A; JOHNSTON J; TAUB D; SPRENGER H; OPPENHEIM J; KELVIN D, 1993, 'IL-8 RECEPTOR REGULATION IN POLYMORPHONUCLEAR LEUKOCYTES BY G-CSF AND LPS', in JOURNAL OF LEUKOCYTE BIOLOGY, FEDERATION AMER SOC EXP BIOL, pp. 48 - 48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993ME18500087&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Taub DD; Lloyd AR; Wang JM; Oppenheim JJ; Kelvin DJ, 1993, 'The effects of human recombinant MIP-1α, MIP-1β, and rantes on the chemotaxis and adhesion of T cell subsets', in Advances in Experimental Medicine and Biology, pp. 139 - 146, http://dx.doi.org/10.1007/978-1-4615-2952-1_15

OPPENHEIM JJ; WANG JM; LLOYD AW; ANDERSON AO, 1991, 'ROLE OF INFLAMMATORY CYTOKINES IN ALLERGY', in Miyamoto T; Okuda M (ed.), PROGRESS IN ALLERGY AND CLINICAL IMMUNOLOGY, VOL 2, KYOTO, HOGREFE & HUBER PUBLISHERS, JAPAN, KYOTO, pp. 445 - 450, presented at 14TH INTERNATIONAL CONGRESS OF ALLERGOLOGY AND CLINICAL IMMUNOLOGY, JAPAN, KYOTO, 13 October 1991 - 18 October 1991, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1992BX58P00080&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lloyd AR, 1990, 'Muscle versus brain: Chronic fatigue syndrome', in Medical Journal of Australia, pp. 530 - 534, http://dx.doi.org/10.5694/j.1326-5377.1990.tb126193.x

Conference Posters

Cunningham EB; Hajarizadeh B; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Bretana NA; Dolan K; Lloyd AR; Grebely J, 2018, 'A161 ONGOING INCIDENT HEPATITIC C VIRUS INFECTION AMONG PEOPLE WITH A HISTORY OF INJECTING DRUG USE IN AN AUSTRALIAN PRISON SETTING', Vol. 1, pp. 278 - 280, http://dx.doi.org/10.1093/jcag/gwy008.162

Conference Presentations

Lafferty L; Sheehan Y; Cochrane A; Grebely J; Lloyd A; Treloar C, 2022, 'The role of point-of-care hepatitis C RNA testing at prison intake for reducing barriers to the hepatitis C care cascade', presented at Australasian Viral Hepatitis Conference, Brisbane, 29 May 2022 - 31 May 2022

Lafferty L; Rance J; Grebely J; Dore G; Lloyd A; Treloar C, 2021, 'Perceptions and concerns of hepatitis c reinfection in the prison setting', presented at Justice Health Conference, Public Health Association Australia, Virtual (Australia), 03 November 2021 - 04 November 2021

Lafferty L; Rance J; Grebely J; Dore G; Lloyd A; Treloar C, 2021, 'Correctional Officers and Health Staff Perspectives Of Hepatitis C Treatment As Prevention Scale Up Within The Prison Setting', presented at International Conference on Health and Hepatitis in Substance Users (INHSU), Virtual (International), 13 October 2021 - 15 October 2021

Lafferty L; Rance J; Dore G; Lloyd A; Treloar C, 2021, 'Scaling Up Hepatitis C Treatment within the Prison Setting: The Role of Social Capital', presented at Academic and Health Policy Conference on Correctional Health (ACCJH), Virtual (USA), 08 April 2021 - 10 April 2021

Sazzad H; Arroyo B; Bull R; Lloyd A; Rodrigo C, 2021, 'Optimised approach for high throughput hepatitis C virus amplification for transmission cluster identification in Australian prisons', presented at 16th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Bowral, Australia

Rodrigo C; Leung P; Adikari T; Riaz N; Bull R; Sigera C; Weeratunga P; Rajapakse S; Lloyd A; Fernando D, 2020, 'Resolving within-host, full length, dengue virus variants without haplotype reconstruction using Oxford Nanopore Technology', presented at ECCMID 2020, Paris, France

Rodrigo C; Riaz N; Adikari T; Sigera C; Rajapakse S; Fernando D; Weeratunga P; Fink K; Bull R; Luciani F; Lloyd A, 2019, 'A single nested PCR method for full length dengue virus genome amplification', presented at 7th European Congress of Virology, Rotterdam, The Netherlands

Rodrigo C; Leung P; Bull R; Lloyd A; Luciani F, 2019, 'Using networks to study epistatic interactions of HCV', presented at 14th Scientific Workship of the Australian Center for HIV and Hepatitis Virology Research, Canungra, Australia

Riaz N; Bull R; Leung P; Smith M; Barton K; Lloyd A; Rodrigo C, 2019, 'Whole genome long read sequencing of Hepatitis C virus and its applications', presented at 14th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Canungra, Australia

Abayasingam A; Leung P; Luciani F; Bull R; Lloyd A; Rodrigo C, 2018, 'Challenges in characterizing hepatitis C virus founder variants with deep sequencing', presented at 13th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research

Rodrigo C; Eltahla A; Bull R; Luciani F; Lloyd A, 2018, 'Genetic variability of Hepatitis C quasi-species in early infection', presented at Global Hepatitis Summit, Toronto, Canada

Rodrigo C; Eltahla A; Bull R; Luciani F; Lloyd A, 2018, 'Host IFNλ3 genotype and viral genotype are key determinants of within-host HCV genomic variation in early infection', presented at 13th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Yarra Valley, Australia

Byrne M; Hajarizadeh B; Dore GJ; Treloar C; Marks P; Milat A; Bowman J; McGrath C; Bath N; Calder I; Lagios K; Grebely J; Lloyd A, 2017, 'A framework for hepatitis C virus treatment as prevention in the prison setting: the SToP-C implementation toolkit', presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)31387-9

Rodrigo C; Eltahla A; Bull R; Luciani F; Lloyd A, 2017, 'Establishment of InC3 viral sequence repository and its applications', presented at 12th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Barossa Valley, Australia

Rodrigo C; Eltahla A; Bull R; Lloyd A; Luciani F, 2016, 'Bayesian evolutionary analysis of hepatitis C epidemic in Australia and North America in 20th century', presented at Australasian Viral Hepatitis Conference, GoldCoast, Australia

Rodrigo C; Eltahla A; Bull R; Lloyd A; Luciani F, 2016, 'Bayesian evolutionary analysis of hepatitis C epidemic in Australia and North America in 20th century', presented at International conference in Systems Biology, Barcelona, Spain

Rodrigo C; Eltahla A; Bull R; Lloyd A; Luciani F, 2016, 'Broadly neutralizing antibodies against hepatitis C envelope; using a network approach to understand co-evolution of critical residues', presented at International conference in Systems Biology, Barcelona, Spain

Rodrigo C; Bretana N; Luciani F; Lloyd A; Bull R, 2016, 'Examining past and future hepatitis C virus epidemic trends in the era of directly acting antivirals', presented at Australian Society of Microbiology annual scientific meeting, Perth, Australia

Rodrigo C; Eltahla A; Bull R; Luciani F; Lloyd A, 2016, 'Molecular epidemiology of full length hepatitis C virus genomes among injecting drug users with recent infection: The InC3 study', presented at 5th International Symposium on Hepatitis Care in Substance Users, Oslo, Norway

Rodrigo C; Eltahla A; Bull R; Luciani F; Lloyd A, 2016, 'Trends of Hepatitis C virus infections in North America and Australia in 20th century; back projections from molecular epidemiology', presented at 5th International Symposium on Hepatitis Care in Substance Users, Oslo, Norway

Leung P; Walker M; Rodrigo C; Eltahla A; Bull R; Lloyd A; Luciani F, 2015, 'A network approach for the identification of co-evolving mutations in Hepatitis C Virus (HCV) in the context of immune escape against neutralizing antibody responses', presented at COMBINE Student Symposium, Sydney, Australia

Walker M; Leung P; Rodrigo C; Eltahla A; Lloyd A; Foung S; Luciani F; Bull R, 2015, 'Characterizing neutralizing antibody responses targeting founder virus in early primary HCV infection with varying disease outcome', presented at International Symposium on Hepatitis C virus and related viruses, Strasbourg, France

Rodrigo C; Eltahla A; Bull R; Luciani F; Lloyd A, 2015, 'Global molecular epidemiology of acute hepatitis infection via phylogenetic analysis of full length genomes across nine international cohorts', presented at 11th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Hunter Valley, Australia

Leung P; Walker M; Rodrigo C; Eltahla A; Bull R; Lloyd A; Luciani F, 2015, 'Identification of co-evolving mutations of the Hepatitis C virus in the context of immune escape against neutralizing antibody responses using a bioinformatics workflow', presented at 8th Australasian virology society meeting, Hunter Valley, Australia

Eltahla A; Rodrigo C; Bull R; Luciani F; Lloyd A, 2015, 'Natural prevalence of HCV resistance associated variants in treatment naïve patients across six genotypes', presented at 11th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Hunter Valley, Australia

Walker M; Leung P; Eltahla A; Rodrigo C; Luciani F; Foung S; Lloyd A; Bull R, 2015, 'Understanding the timing, breadth and potency of neutralising antibody responses against transmitted/founders', presented at 11th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Hunter Valley, Australia

Conference Abstracts

Carson J; Dore G; Lloyd A; Grebely J; Byrne M; Cunningham EB; Amin J; Vickerman P; Martin N; Treloar C; Matthews G; Hajarizadeh B, 2022, 'Hepatitis C virus reinfection following direct acting antiviral treatment in the prison setting: the SToP-C study', in Journal of Hepatology, Elsevier BV, Vol. 77, pp. S565 - S565, http://dx.doi.org/10.1016/s0168-8278(22)01451-9

Thilakanathan C; Kayes T; Di Girolamo J; Nguyen V; Lloyd A; Levy MT, 2021, 'BASELINE PREDICTORS OF POST-PARTUM HEPATITIS B E ANTIGEN SEROCONVERSION', in HEPATOLOGY, WILEY, Vol. 74, pp. 446A - 447A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000707188002141&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Brasher NA; Eltahla AA; Underwood A; Tedla N; Lloyd AR; Bull RA, 2020, 'B cell immunodominance in primary hepatitis C virus infection', in JOURNAL OF HEPATOLOGY, ELSEVIER, Vol. 72, pp. E38 - E38, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000520050900030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Howe A; De Salazar A; Aragri M; Popping S; Fourati S; Tay E; Rodrigo C; Cunningham E; Kjellin M; Fernando Fay F; Newton E; Sfalcin J; Gomes P; Boucher CA; De Knegt R; Poljak M; Lunar M; Salmon D; Usubillaga R; Sayan M; Mor O; Seguin-Devaux C; Lloyd A; Pawlotsky J-M; Grebely J; Lennerstrand J; Knops E; Kaiser R; Chulanov V; Rincon P; Martinez-Sapina A; Galera C; Douglas M; Silberstein FC; Harrigan R; Garcia Garcia F, 2019, 'GENOTYPE MISCLASSIFICATION NEGATIVELY IMPACT THE CHOICE OF REGIMENS AND TREATMENT OUTCOMES IN THE MANAGEMENT OF HEPATITIS C', in HEPATOLOGY, WILEY, MA, Boston, Vol. 70, pp. 318A - 319A, presented at Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, MA, Boston, 08 November 2019 - 12 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488653501070&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Fourati S; Silberstein FC; Howe A; De Salazar A; Popping S; Di Maio VC; Tay E; Rodrigo C; Cunningham E; Kjellin M; Sfalcin J; Gomes P; Poljak M; Lunar M; Sayan M; Mor O; Salmon D; Usubillaga R; Seguin-Devaux C; Boucher CA; Poiteau L; Lloyd A; Grebely J; Lennerstrand J; Kaiser R; Zhigalkina P; Fernando Fay F; Aragri M; Chulanov V; Garcia-Deltoro M; Cabezas J; Carlos Alados J; De Knegt RJ; Douglas M; Garcia FG; Harrigan R; Pawlotsky J-M, 2019, 'HCV RESISTANCE PATTERNS IN A WORLDWIDE NETWORK OF COHORTS OF GT-3a INFECTED PATIENTS', in HEPATOLOGY, WILEY, MA, Boston, Vol. 70, pp. 180A - 181A, presented at Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, MA, Boston, 08 November 2019 - 12 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488653500277&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Popping S; Fourati S; Howe A; Di Maio VC; Tay E; Rodrigo C; Cunningham E; Kjellin M; Sfalcin J; Gomes P; Poljak M; Lunar M; Sayan M; Mor O; Salmon D; Usubillaga R; Omar M; Garcia-Bujalance S; Tellez F; Fuentes A; Seguin-Devaux C; Soulier A; Lloyd A; Grebely J; Aragri M; Lennerstrand J; Kaiser R; Zhigalkina P; Chulanov V; De Knegt RJ; Douglas M; Silberstein FC; Harrigan R; Garcia FG; Boucher CA; Pawlotsky J-M, 2019, 'THE GLOBAL PREVALENCE OF RESISTANCE ASSOCIATED SUBSTITUTIONS (RASS) IN "UNUSUAL" HCV SUBTYPES', in HEPATOLOGY, WILEY, MA, Boston, Vol. 70, pp. 77A - 78A, presented at Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, MA, Boston, 08 November 2019 - 12 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488653500117&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Weickert T; Jacomb I; Lenroot R; Lappin J; Weinberg D; Brooks W; Brown D; Pellen D; Kindler J; Mohan A; Wakefield D; Lloyd A; Stanton C; O'Donnell M; Liu D; Galletly C; Weickert CS, 2019, 'Reduction in Peripheral C-Reactive Protein Levels With Canakinumab Administration is Related to Reduced Positive Symptom Severity in Patients With Schizophrenia and Inflammation', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, IL, Chicago, Vol. 85, pp. S44 - S45, presented at 74th Annual Meeting of the Society-of-Biological-Psychiatry (SOBP), IL, Chicago, 16 May 2019 - 18 May 2019, http://dx.doi.org/10.1016/j.biopsych.2019.03.121

Weickert T; Jacomb I; Lenroot R; Lappin J; Weinberg D; Brooks W; Brown D; Pellen D; Kindler J; Mohan A; Wakefield D; Lloyd A; Stanton C; O'Donnell M; Liu D; Galletly C; Weickert CS, 2019, 'REDUCTION IN PERIPHERAL C-REACTIVE PROTEIN LEVELS WITH CANAKINUMAB ADMINISTRATION IS RELATED TO REDUCED POSITIVE SYMPTOM SEVERITY IN PATIENTS WITH SCHIZOPHRENIA AND INFLAMMATION', in SCHIZOPHRENIA BULLETIN, OXFORD UNIV PRESS, FL, Orlando, Vol. 45, pp. S318 - S318, presented at Congress of the Schizophrenia-International-Research-Society (SRIS), FL, Orlando, 10 April 2019 - 14 April 2019, http://dx.doi.org/10.1093/schbul/sbz020.578

Bartlett SR; Grebely J; Eltahla AA; Reeves JD; Howe A; Miller V; Bull RA; Ceccherini-Silberstein F; Douglas MW; Dore GJ; Harrington P; Lloyd AR; Jacka B; Matthews GV; Wang GP; Pawlotsky J-M; Feld JJ; Schinkel J; Garcia F; Lennerstrand J; Applegate TL, 2017, 'Systematic review & expert guidance on methods for sequencing of hepatitis C virus for detection of direct-acting antiviral resistance', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, Vol. 66, pp. S323 - S323, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)30970-4

Connor SJ; Cardillo R; Cuan N; Amansec S; Conway P; Lloyd AR; Grimm MC, 2001, 'Amelioration of TNBS colitis in mice using prebiotics', in GASTROENTEROLOGY, W B SAUNDERS CO, Vol. 120, pp. A82 - A82, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000168514700403&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Connor SJ; Hassim Z; Cardillo R; Lloyd AR; Grimm MC, 2000, 'Chemokine receptor expression and function in lamina propria mononuclear cells of the human colon.', in GASTROENTEROLOGY, W B SAUNDERS CO, Vol. 118, pp. A355 - A355, http://dx.doi.org/10.1016/S0016-5085(00)83524-6

Back to profile page